Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-024096
Filing Date
2025-09-10
Accepted
2025-09-10 16:50:25
Documents
2
Period of Report
2025-09-08

Document Format Files

Seq Description Document Type Size
1 form3-09102025_080921.html 3  
1 form3-09102025_080921.xml 3 1699
2 ex24-09102025_080922.htm EX-24 13648
  Complete submission text file 0001415889-25-024096.txt   17101
Mailing Address C/O INCYTE CORPORATION-EXPERIMENTAL STN. ROUTE 141 & HENRY CLAY RD., BLDG. E336 WILMINGTON DE 19880
Business Address
Hoppenot Herve (Reporting) CIK: 0001596492 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38916 | Film No.: 251306411

Mailing Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS
Business Address BLOCKS A & B, PORTWAY BUILDING GRANTA PARK, GREAT ABINGTON CAMBRIDGE X0 CB21 6GS 011441223261503
BICYCLE THERAPEUTICS PLC (Issuer) CIK: 0001761612 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)